scispace - formally typeset
H

H. Van den Berghe

Researcher at Katholieke Universiteit Leuven

Publications -  413
Citations -  15955

H. Van den Berghe is an academic researcher from Katholieke Universiteit Leuven. The author has contributed to research in topics: Chromosomal translocation & Trisomy. The author has an hindex of 65, co-authored 413 publications receiving 15692 citations. Previous affiliations of H. Van den Berghe include Ludwig Institute for Cancer Research & Catholic University of Leuven.

Papers
More filters
Journal ArticleDOI

Developmental changes in heparan sulfate expression: in situ detection with mAbs.

TL;DR: The results suggest that heparan sulfate abounds at sites of active morphogenesis and that the expression of this glycosaminoglycan is developmentally regulated.
Journal Article

Correlation between clinicopathological features and karyotype in lipomatous tumors. A report of 178 cases from the Chromosomes and Morphology (CHAMP) Collaborative Study Group.

TL;DR: It is concluded that cytogenetic abnormalities are common in lipomatous tumors, correlate reliably with morphological sub-type in many cases, and can be of diagnostic value in histologically borderline or difficult cases.
Journal ArticleDOI

Molecular cloning of a phosphatidylinositol-anchored membrane heparan sulfate proteoglycan from human lung fibroblasts.

TL;DR: The characterization of human lung fibroblast cDNAs that encode the message for these core proteins and the effect of bacterial phosphatidylinositol-specific phospholipase C suggest that the hydrophobic proteoglycan is membrane-anchored through aospholipid tail.
Journal ArticleDOI

Stimulation of fibroblast growth factor receptor-1 occupancy and signaling by cell surface-associated syndecans and glypican.

TL;DR: It is concluded that, at least in K562 cells, syndecans and glypican can support bFGF-FGFR1 interactions and signaling, and that cell-surface association may augment their effectiveness.
Journal ArticleDOI

Cell surface heparan sulfate proteoglycans from human vascular endothelial cells. Core protein characterization and antithrombin III binding properties.

TL;DR: The results imply that glypican may specifically contribute to the antithrombotic properties of the vascular wall.